Published papers
Academic conference presentation
Education
    （Last updated : 2026-02-13 14:19:15）
  IIDZUKA Jiyunpei
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Associate Professor
■ Published papers
1. Original article　 Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma. 2026/01
2. Original article　 Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end‑stage renal disease populations. 2025/12
3. Original article　 Renal function with enfortumab vedotin in metastatic urothelial carcinoma: A multicenter retrospective study in Japan. 2025/12
4. Original article　 Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma. 2025/10
5. Case report　 Safety of enfortumab vedotin plus pembrolizumab in hemodialysis patients with metastatic urothelial carcinoma: Case report 2025/09/01
Display all(172)
■ Academic conference presentation
1. Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. （ポスター掲示，一般） 2025/09/26
2. Long-Term Outcomes of High-Dose-Rate Brachytherapy Combined with Hypofractionated External Beam Radiotherapy for High-Risk Localized Prostate Cancer （ポスター掲示，一般） 2025/05
3. Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. （ポスター掲示，一般） 2025/04/29
4. Impact of cytoreductive nephrectomy on immunecheckpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies formetastatic renal cell carcinoma with primary kidneytumors. （ポスター掲示，一般） 2025/04/28
5. Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. （ポスター掲示，一般） 2025/04/27
Display all(156)
■ Education
1. 1991/04～1997/03 Faculty of Medicine, Asahikawa Medical College, Graduated, Docter of Medicine